These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 22212097)
1. Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition. Liu Z; Sun B; Qi L; Li H; Gao J; Leng X Cancer Sci; 2012 Apr; 103(4):813-20. PubMed ID: 22212097 [TBL] [Abstract][Full Text] [Related]
2. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231. Liang W; Song S; Xu Y; Li H; Liu H Mol Med Rep; 2018 May; 17(5):6711-6716. PubMed ID: 29512767 [TBL] [Abstract][Full Text] [Related]
4. PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT. Li W; Wu J; Jia Q; Shi Y; Li F; Zhang L; Shi F; Wang X; Wu S BMC Cancer; 2024 May; 24(1):633. PubMed ID: 38783271 [TBL] [Abstract][Full Text] [Related]
5. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702 [TBL] [Abstract][Full Text] [Related]
6. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer. Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342 [TBL] [Abstract][Full Text] [Related]
7. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765 [TBL] [Abstract][Full Text] [Related]
8. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition. Yang Z; Wu D; Chen Y; Min Z; Quan Y Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022 [TBL] [Abstract][Full Text] [Related]
9. IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells. Cao H; Zhang J; Liu H; Wan L; Zhang H; Huang Q; Xu E; Lai M Oncotarget; 2016 Sep; 7(38):61183-61198. PubMed ID: 27533463 [TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328 [No Abstract] [Full Text] [Related]
11. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364 [TBL] [Abstract][Full Text] [Related]
12. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer. Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751 [TBL] [Abstract][Full Text] [Related]
13. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition. Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer. Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377 [TBL] [Abstract][Full Text] [Related]
15. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process. Shi Y; Li W; Jia Q; Wu J; Wu S; Wu S Exp Cell Res; 2024 Apr; 437(1):113996. PubMed ID: 38508327 [TBL] [Abstract][Full Text] [Related]
17. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
18. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Song X; An Y; Chen D; Zhang W; Wu X; Li C; Wang S; Dong W; Wang B; Liu T; Zhong W; Sun T; Cao H Cancer Sci; 2022 Feb; 113(2):459-477. PubMed ID: 34811848 [TBL] [Abstract][Full Text] [Related]
19. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT. Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277 [TBL] [Abstract][Full Text] [Related]
20. ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells. Langer EM; Kendsersky ND; Daniel CJ; Kuziel GM; Pelz C; Murphy KM; Capecchi MR; Sears RC Oncogene; 2018 Feb; 37(8):1005-1019. PubMed ID: 29084210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]